Immune Design Corp buy melinda
Start price
15.03.17
/
50%
€5.77
Target price
17.03.17
€6.31
Performance (%)
10.16%
End price
17.03.17
€6.36
Summary
This prediction ended on 17.03.17 with a price of €6.36. The prediction had a final performance of 10.16%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immune Design Corp | - | - | - | - |
| iShares Core DAX® | -1,74 % | 5,98 % | 8,98 % | 49,86 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % | 38,41 % | 100,33 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % | 46,68 % | 65,35 % |
| iShares S&P 500 | 0,97 % | 7,62 % | 28,14 % | 68,66 % |
Comments by melinda for this prediction
In the thread Immune Design Corp diskutieren
Tumoren
CMB305
Krebs - soliden Tumoren
(Zielkurs erreicht)
Stopped prediction by melinda for Immune Design Corp
Immune Design Corp
Start price
Target price
Perf. (%)
€4.56
01.11.17
01.11.17
€9.92
19.12.17
19.12.17
-23.27%
19.12.17
19.12.17


